Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Heritage Insurance Holdings (HRTG) Asset Writedowns and Impairment (2022 - 2023)

Heritage Insurance Holdings' Asset Writedowns and Impairment history spans 2 years, with the latest figure at $767000.0 for Q2 2023.

For Q2 2023, Asset Writedowns and Impairment fell 99.17% year-over-year to $767000.0; the TTM value through Sep 2024 reached $767000.0, changed 0.0%, while the annual FY2023 figure was $767000.0, 99.17% down from the prior year.
Asset Writedowns and Impairment reached $767000.0 in Q2 2023 per HRTG's latest filing, down from $92.0 million in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $92.0 million in Q2 2022 to a low of $767000.0 in Q2 2023.